Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets -- Ignore unavailable to you. Want to Upgrade?

To: richardred who wrote (1163)	3/31/2006 10:05:13 AM
From: richardred	Respond to of 7243

Possible reason? Arrow SmartSeal(TM) Sheath: Unique Valve Design for Use with Chronic Hemodialysis Catheters Friday March 31, 8:00 am ET READING, Pa.--(BUSINESS WIRE)--March 31, 2006--Air embolism is a serious concern with the insertion of dialysis catheters. Although perceived as infrequent, the effects are potentially fatal. Physicians need a simple, safe way to manage this risk. Arrow International's (Nasdaq:ARRO - News) response: the Arrow SmartSeal Hemostatic Peelable Dialysis Sheath, available in the United States both individually and in select chronic hemodialysis catheter kits. The "brain" of the SmartSeal sheath is a unique dual hemostatic valve that plays three critical roles, says Arrow's Jim Fitzpatrick, Vice President of Special Procedures Business Unit. "It's designed to minimize risk of air embolism, minimize blood loss and reduce clinicians' exposure to blood-borne pathogens during the entire catheterization procedure." SmartSeal is also engineered to ease insertion, with user-friendly features including: * Easy-to-grip tabs * Easy-to-peel sheath with break-away hemostatic valve * A sheath tip that enables smooth, atraumatic transition during insertion Source: Arrow International · The Arrow SmartSeal Hemostatic Peelable Dialysis Sheath; a simple, safe way to minimize risk of air embolism, minimize blood loss and reduce clinicians' exposure to blood-borne pathogens. (Photo:Business Wire) . View Multimedia Gallery "The SmartSeal sheath exemplifies Arrow's commitment to safety and protection for patients and healthcare workers," Fitzpatrick says. Arrow International's suite of catheter-based dialysis devices includes the Arrow Cannon® II Plus Retrograde-Tunneled, Tip-First Chronic Hemodialysis Catheter, the Arrow Edge(TM) Antegrade-Tunneled Chronic Hemodialysis Catheter, the Arrow Simplicity(TM) Color-Coded Micro-Puncture Introducer Set and the Arrow-Trerotola(TM) PTD®. Each is created in close consultation with the experts who use them, then designed with the unique features these experts need to treat their patients successfully. The resulting dialysis devices are as easy to use as they are effective. Company Information Arrow International, Inc. develops, manufactures and markets a broad range of clinically advanced, disposable catheters and related products for critical and cardiac care. The Company's products are used primarily by anesthesiologists, critical care specialists, surgeons, emergency and trauma physicians, cardiologists, interventional radiologists, electrophysiologists, and other healthcare providers. Arrow International's news releases and other company information can be found on its website at arrowintl.com. The Company's common stock trades on The Nasdaq Stock Market® under the symbol ARRO. MULTIMEDIA AVAILABLE: businesswire.com Contact: Media contact: VIA for Arrow International Karla McGowan, 207-221-3000 x1230 kmcgowan@vianow.com or Investor contact: Arrow International, Inc. Fred Hirt, 610-478-3117 Chief Financial Officer Source: Arrow International